Isovaleriaanse acidemie als gevolg van samengestelde heterozygote varianten van het IVD- gen in een geval
Doelstelling: De klinische kenmerken, biochemische kenmerken en moleculaire pathogenese van een meisje met isovaleriaanse acidemie analyseren .
Methoden: Klinische kenmerken, aminozuurprofielen van bloedvlekken en profielen van organische zuren in urine van de patiënt werden geanalyseerd. Gerichte seize, subsequent era sequencing en Sanger- sequencing werden uitgevoerd om mogelijke varianten van het IVD-gen te detecteren.
Resultaten: De patiënt vertoonde 10 dagen na de geboorte een slechte gewichtstoename, slechte voeding, lethargie en een geur van “zweetvoeten”. Biochemische take a look at suggereerde hyperammoniëmie. Bloedvlek-aminozuurprofielen vertoonden een dramatische toename van isovalerylcarnitine (C5: 3 044, referentiebereik 0,04 – 0,four μmol / l).Analyse van organisch zuur van haar urinemonster onthulde een hoog gehalte aan isovaleriaanzuurglycine (669. 53, referentiebereik 0 – 0,5). Het form werd uiteindelijk gediagnosticeerd met isovaleriaanzuuracidemie, en bleek een vaderlijk afgeleide heterozygote variant c.149G> A (p.R50H) en een maternale heterozygote variant c.1123G> A (p.G375S) van het IVD-gen te herbergen. Haar oudere broer was een heterozygote drager van c.1123G> A (p.G375S) variant. De c.149G> A (p.R50H) was een bekende pathogene variant, terwijl de c.1123G> A (p.G375S) -variant voorheen niet werd gerapporteerd.
Celgebaseerde strategieën voor IVD- reparatie: klinische vooruitgang en translationele obstakels
Degeneratie van de tussenwervelschijf (IVD) is een belangrijke oorzaak van lage rugpijn, een veel voorkomende en chronische aandoening die een opvallend impact heeft op de kwaliteit van leven. Momenteel zijn er geen goedgekeurde farmacologische interventies of therapieën beschikbaar die de progressieve vernietiging van de IVD voorkomen; er zijn echter regeneratieve strategieën in opkomst die tot doel hebben de ziekte te wijzigen. Er is vooruitgang geboekt bij het definiëren van veelbelovende nieuwe behandelingen voor discopathie, maar er blijven aanzienlijke uitdagingen over het hele translationele spectrum, van het begrijpen van het ziektemechanisme tot bruikbare interpretatie van klinische onderzoeken, die het moeilijk maken om een uniform begrip te bereiken.
Deze uitdagingen omvatten: een onvolledige waardering van de mechanismen van schijfdegeneratie; een gebrek aan gestandaardiseerde benaderingen bij preklinische testen; in de context van celtherapie, een duidelijk gebrek aan samenhang met betrekking tot de celtypen die worden getest, de weefselbron, expansievoorwaarden en dosis; het ontbreken van richtlijnen met betrekking tot ziekteclassificatie en patiëntstratificatie voor opname in klinische proeven; en een onvolledig begrip van de mechanismen die aan de therapie ten grondslag liggenreacties op celaflevering. Deze recensie bespreekt de huidige benaderingen van schijfregeneratie, met een bijzondere focus op celgebaseerde therapeutische strategieën, inclusief voortdurende uitdagingen, en pogingen om een raamwerk te bieden om huidige gegevens te interpreteren en toekomstige onderzoeksstudies te begeleiden.
Onderzoek naar toepassing van clever traceersysteem voor IVD- reagentia op foundation van blockchain-technologie
speelt een belangrijke rol bij ziektepreventie, klinische diagnose, gezondheidsmonitoring en begeleiding van de behandeling. Daarom zijn de gevolgde kwaliteits- en veiligheidskwesties zeer bezorgd. De unieke voordelen van blockchain-technologie, decentralisatie, wantrouwen en niet-knoeien, kunnen in vertrouwde knooppuntgegevens schrijven in elke hyperlink die de productie, circulatie en gebruik van IVD- reagentia omvat, en een gedistribueerd grootboek opzetten met volledige back-up, waardoor traceerbaarheid voor IVD-reagentia mogelijk. We bespreken een clever volgsysteem voor het hele proces voor IVD-reagentia op foundation van blockchain-technologie. Door het sterke mechanisme van pre-supervisie en poststraf kan de bron van reagentia worden achterhaald, kunnen kwaliteit en verantwoordelijkheid worden onderzocht en kunnen de kwaliteit van de medische inspectie en diagnostische veiligheid worden bewaakt.
Description: Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
Description: Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
Description: Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
Description: Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
Description: Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
Description: Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
Description: Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
Description: Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyper-ferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
Description: Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyper-ferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
Description: Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyper-ferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
Description: Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
Description: Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
Description: Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
Description: Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
Description: Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
Description: Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
Description: Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. Also plays a role in delivery of iron to cells. Mediates iron uptake in capsule cells of the developing kidney. [UniProt]
Description: Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
Description: Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
Description: Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
Description: Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
Description: The FTL gene encodes the light subunit of the ferritin protein. Ferritin is the major intracellular iron storage protein in prokaryotes and eukaryotes. It is composed of 24 subunits of the heavy and light ferritin chains. Variation in ferritin subunit composition may affect the rates of iron uptake and release in different tissues. A major function of ferritin is the storage of iron in a soluble and nontoxic state. This gene has multiple pseudogenes.
Although ferritin light chain has no ferroxidase activity, the light chain may be responsible for the electron transfer across the ferritin protein cage. [Wiki]
Description: The FTL gene encodes the light subunit of the ferritin protein. Ferritin is the major intracellular iron storage protein in prokaryotes and eukaryotes. It is composed of 24 subunits of the heavy and light ferritin chains. Variation in ferritin subunit composition may affect the rates of iron uptake and release in different tissues. A major function of ferritin is the storage of iron in a soluble and nontoxic state. This gene has multiple pseudogenes.
Although ferritin light chain has no ferroxidase activity, the light chain may be responsible for the electron transfer across the ferritin protein cage. [Wiki]
Description: The FTL gene encodes the light subunit of the ferritin protein. Ferritin is the major intracellular iron storage protein in prokaryotes and eukaryotes. It is composed of 24 subunits of the heavy and light ferritin chains. Variation in ferritin subunit composition may affect the rates of iron uptake and release in different tissues. A major function of ferritin is the storage of iron in a soluble and nontoxic state. This gene has multiple pseudogenes.
Although ferritin light chain has no ferroxidase activity, the light chain may be responsible for the electron transfer across the ferritin protein cage. [Wiki]
Description: The FTL gene encodes the light subunit of the ferritin protein. Ferritin is the major intracellular iron storage protein in prokaryotes and eukaryotes. It is composed of 24 subunits of the heavy and light ferritin chains. Variation in ferritin subunit composition may affect the rates of iron uptake and release in different tissues. A major function of ferritin is the storage of iron in a soluble and nontoxic state. This gene has multiple pseudogenes.
Although ferritin light chain has no ferroxidase activity, the light chain may be responsible for the electron transfer across the ferritin protein cage. [Wiki]
Description: The FTL gene encodes the light subunit of the ferritin protein. Ferritin is the major intracellular iron storage protein in prokaryotes and eukaryotes. It is composed of 24 subunits of the heavy and light ferritin chains. Variation in ferritin subunit composition may affect the rates of iron uptake and release in different tissues. A major function of ferritin is the storage of iron in a soluble and nontoxic state. This gene has multiple pseudogenes.
Although ferritin light chain has no ferroxidase activity, the light chain may be responsible for the electron transfer across the ferritin protein cage. [Wiki]
Description: The FTL gene encodes the light subunit of the ferritin protein. Ferritin is the major intracellular iron storage protein in prokaryotes and eukaryotes. It is composed of 24 subunits of the heavy and light ferritin chains. Variation in ferritin subunit composition may affect the rates of iron uptake and release in different tissues. A major function of ferritin is the storage of iron in a soluble and nontoxic state. This gene has multiple pseudogenes.
Although ferritin light chain has no ferroxidase activity, the light chain may be responsible for the electron transfer across the ferritin protein cage. [Wiki]
Description: The FTL gene encodes the light subunit of the ferritin protein. Ferritin is the major intracellular iron storage protein in prokaryotes and eukaryotes. It is composed of 24 subunits of the heavy and light ferritin chains. Variation in ferritin subunit composition may affect the rates of iron uptake and release in different tissues. A major function of ferritin is the storage of iron in a soluble and nontoxic state. This gene has multiple pseudogenes.;;Although ferritin light chain has no ferroxidase activity, the light chain may be responsible for the electron transfer across the ferritin protein cage. [Wiki]
Description: The FTL gene encodes the light subunit of the ferritin protein. Ferritin is the major intracellular iron storage protein in prokaryotes and eukaryotes. It is composed of 24 subunits of the heavy and light ferritin chains. Variation in ferritin subunit composition may affect the rates of iron uptake and release in different tissues. A major function of ferritin is the storage of iron in a soluble and nontoxic state. This gene has multiple pseudogenes.;;Although ferritin light chain has no ferroxidase activity, the light chain may be responsible for the electron transfer across the ferritin protein cage. [Wiki]
Description: The FTL gene encodes the light subunit of the ferritin protein. Ferritin is the major intracellular iron storage protein in prokaryotes and eukaryotes. It is composed of 24 subunits of the heavy and light ferritin chains. Variation in ferritin subunit composition may affect the rates of iron uptake and release in different tissues. A major function of ferritin is the storage of iron in a soluble and nontoxic state. This gene has multiple pseudogenes.;;Although ferritin light chain has no ferroxidase activity, the light chain may be responsible for the electron transfer across the ferritin protein cage. [Wiki]
Description: The FTL gene encodes the light subunit of the ferritin protein. Ferritin is the major intracellular iron storage protein in prokaryotes and eukaryotes. It is composed of 24 subunits of the heavy and light ferritin chains. Variation in ferritin subunit composition may affect the rates of iron uptake and release in different tissues. A major function of ferritin is the storage of iron in a soluble and nontoxic state. This gene has multiple pseudogenes.;;Although ferritin light chain has no ferroxidase activity, the light chain may be responsible for the electron transfer across the ferritin protein cage. [Wiki]
Description: Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
Description: Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
Description: Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
Description: A Monoclonal antibody against Human Ferritin (heavy chain). The antibodies are raised in Rabbit and are from clone EPR3005Y. This antibody is applicable in WB and IHC
Description: A competitive ELISA for quantitative measurement of Mouse Ferritin light chain(FTL) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Mouse Ferritin light chain(FTL) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Mouse Ferritin light chain(FTL) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A Monoclonal antibody against Human Ferritin Heavy Chain / FTH1 (clone 3F8). The antibodies are raised in Mouse and are from clone 3F8. This antibody is applicable in WB and IHC-P, E
Mouse Anti Duck Igy Light Chain Monoclonal Antibody
Description: Quantitativesandwich ELISA kit for measuring Human Ferritin light chain (FTL) in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.
Description: Quantitativesandwich ELISA kit for measuring Human Ferritin light chain(FTL) in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.
Description: A competitive ELISA for quantitative measurement of Human Ferritin light chain(FTL) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Human Ferritin light chain(FTL) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Human Ferritin light chain(FTL) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: Enzyme-linked immunosorbent assay kit for quantification of Human Ferritin light chain in samples from serum, plasma, tissue homogenates and other biological fluids.
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human FTL / Ferritin Light Chain (C-Terminus). This antibody is tested and proven to work in the following applications:
IMDRF essentiële principes van veiligheid en prestaties van medische hulpmiddelen en IVD medische hulpmiddelen Inleiding en overweging
IMDRF heeft de essentiële principes van veiligheid en prestaties van medische hulpmiddelen en medische hulpmiddelen voor IVD (hierna “EP” genoemd) herzien , wat de internationale unificatie van de veiligheid en effectiviteit van medische hulpmiddelen verder heeft bevorderd. Om de wetenschappelijke beoordeling van medische hulpmiddelen te versterken en het begrip van EP te verdiepen, introduceren we EP, richten we ons op de rol van EP en het verband met de constructie van kwaliteitsmanagementsystemen, risico- en batenbepaling en registratie, analyseren we de problemen en redenen in het proces van registratie van medische hulpmiddelen, en geven suggesties om de toepassing van EP te bevorderen.
Diabetes mellitus sort 2 (T2DM) wordt geassocieerd met verrijking van het geavanceerde glycatie-eindproduct (AGE) en wordt beschouwd als een risicofactor voor degeneratie van de tussenwervelschijf (IVD). Onze hypothese was dat systemische AGE-remming, bereikt met pyridoxamine (PM), IVD-degeneratie bij T2DM-ratten verzwakt . Om IVD-degeneratie te induceren, werd een lumbale schijfbeschadiging of een schijnoperatie uitgevoerd op Zucker Diabetic Sprague Dawley (ZDSD) of controle Sprague Dawley (SD) -ratten. Na de operatie kregen IVD-gewonde ZDSD-ratten dagelijks PM opgelost in drinkwater of alleen water. De resulterende groepen waren SD ongedeerd, SD gewond, ZDSD ongedeerd, ZDSD gewond en ZDSD gewond + PM. Niveaus van bloedglycatie en schijfdegeneratie werden onderzocht. In week eight na de operatie , geglyceerd serumeiwit (GSP)niveaus waren verhoogd in ZDSD’s in vergelijking met SD’s. PM-behandeling verzwakte deze toename.
Micro-MRI-analyse toonde IVD-uitdroging aan bij gewonde versus niet-gewonde SD’s en ZDSD’s. In de ZDSD-gewonden + PM-groep was IVD-uitdroging verminderd in vergelijking met ZDSD-gewonden. AGE-niveaus waren verlaagd en aggrecan-niveaus namen toe bij ZDSD-gewonde + PM versus ZDSD- gewonde ratten. Histologische en immunohistochemische analyses ondersteunden verder het gunstige impact van PM. Samenvattend, PM verzwakte GSP-niveaus en IVD-degeneratieprocessen bij ZDSD-ratten, wat het potentieel aantoont om IVD-degeneratie te verzwakken naast het beheersen van glycemie in T2DM.
Een profiel van de door de FDA goedgekeurde en CE / IVD- gemarkeerde Aptima Mycoplasma genitalium assay (Hologic) en de belangrijkste prioriteiten bij de behandeling van M. genitalium- infecties
Inleiding: Mycoplasma genitalium (MG) veroorzaakt vaak asymptomatische soa’s. MG-prevalentiecijfers ontbreken en de behandeling wordt bemoeilijkt door het gebrek aan etiologische diagnostiek en hoge antimicrobiële resistentie in veel landen. Passend gevalideerde, kwaliteitsgegarandeerde en door de FDA goedgekeurde MG-diagnostische assays ontbraken.
Behandelde gebieden: De klinische en analytische prestatiekenmerken van de Aptima® MG Assay, de eerste door de FDA goedgekeurde MG-nucleïnezuuramplificatietest (NAAT), worden samengevat. De belangrijkste prioriteiten bij het beheer en de controle van MG-infecties worden ook besproken.
Mening van deskundigen: zeer gevoelige, specifieke en kwaliteitsgegarandeerde MG NAAT’s, bijv. De Aptima MG-assay op het geautomatiseerde en flexibele Panther®-platform, zijn noodzakelijk om het beheer en de controle van MG-infecties internationaal te verbeteren .
Deze testen, gecombineerd met macrolide resistentie testen (nog niet beschikbaar op het Panther-platform), bieden een snelle, hoge doorvoer en passende diagnose van MG. Bij MG-infecties moet een opeenvolgende behandeling met macrolidenresistentie worden geïmplementeerd. Dubbele antimicrobiële therapie, nieuwe antimicrobiële middelen en, idealiter, een vaccin kunnen essentieel worden.
Description: A competitive ELISA for quantitative measurement of Rat Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Rat Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Rat Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Canine Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Canine Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Canine Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Porcine Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Porcine Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Porcine Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Goat Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Goat Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Goat Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Human Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Human Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Human Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Mouse Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Mouse Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Mouse Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Rabbit Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Rabbit Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Rabbit Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Monkey Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Monkey Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Monkey Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A sandwich quantitative ELISA assay kit for detection of Rat Cystathionine Gamma Lyase (CSE) in samples from tissue homogenates or other biological fluids.
Description: A sandwich quantitative ELISA assay kit for detection of Rat Cystathionine Gamma Lyase (CSE) in samples from tissue homogenates or other biological fluids.
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of for Cystathionine Gamma Lyase (CSE) in Tissue homogenates, cell lysates and other biological fluids.
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of for Cystathionine Gamma Lyase (CSE) in Tissue homogenates, cell lysates and other biological fluids.
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of for Cystathionine Gamma Lyase (CSE) in Tissue homogenates, cell lysates and other biological fluids.
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of for Cystathionine Gamma Lyase (CSE) in Tissue homogenates, cell lysates and other biological fluids.
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Cystathionine Gamma Lyase (CSE) in samples from Tissue homogenates, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species.
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Cystathionine Gamma Lyase (CSE) in Tissue homogenates and other biological fluids.
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Cystathionine Gamma Lyase (CSE) in Tissue homogenates and other biological fluids.
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Cystathionine Gamma Lyase (CSE) in Tissue homogenates and other biological fluids.
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Cystathionine Gamma Lyase (CSE) in Tissue homogenates and other biological fluids.
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Rat Cystathionine Gamma Lyase (CSE) in samples from Tissue homogenates and other biological fluids. with no significant corss-reactivity with analogues from other species.
Description: A sandwich quantitative ELISA assay kit for detection of Human Cystathionine Gamma Lyase (CSE) in samples from tissue homogenates, cell lysates or other biological fluids.
Description: A sandwich quantitative ELISA assay kit for detection of Human Cystathionine Gamma Lyase (CSE) in samples from tissue homogenates, cell lysates or other biological fluids.
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Cystathionine Gamma Lyase (CSE) in tissue homogenates, cell lysates and other biological fluids.
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Cystathionine Gamma Lyase (CSE) in tissue homogenates, cell lysates and other biological fluids.
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Cystathionine Gamma Lyase (CSE) in tissue homogenates, cell lysates and other biological fluids.
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Cystathionine Gamma Lyase (CSE) in tissue homogenates, cell lysates and other biological fluids.
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Cystathionine Gamma Lyase (CSE) in samples from tissue homogenates, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species.
Description: A competitive ELISA for quantitative measurement of Guinea pig Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Guinea pig Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Guinea pig Cystathionine Gamma Lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A sandwich ELISA kit for detection of Cystathionine Gamma Lyase from Rat in samples from blood, serum, plasma, cell culture fluid and other biological fluids.
ELISA kit for Human CSE (Cystathionine Gamma Lyase)
Description: A sandwich ELISA kit for detection of Cystathionine Gamma Lyase from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids.
